Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Long noncoding RNAs (lncRNAs) are functionally associated with cancer development and progression. Although gene copy number variation (CNV) is common in hepatocellular carcinoma (HCC), it is not known how CNV in lncRNAs affects HCC progression and recurrence. We aimed to identify a CNV-related lncRNA involved in HCC progression and recurrence and illustrate its underlying mechanisms and prognostic value.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>We analyzed the whole genome sequencing (WGS) data of matched cancerous and noncancerous liver samples from 49 patients with HCC to identify lncRNAs with CNV. The results were validated in another cohort of 238 paired HCC and nontumor samples by TaqMan copy number assay. We preformed Kaplan-Meier analysis and log-rank test to identify lncRNA CNV with prognostic value. We conducted loss- and gain-of-function studies to explore the biological functions of LINC01133 in vitro and in vivo. The competing endogenous RNAs (ceRNAs) mechanism was clarified by microRNA sequencing (miR-seq), quantitative real-time PCR (qRT-PCR), western blot, and dual-luciferase reporter assays. We confirmed the binding mechanism between lncRNA and protein by RNA pull-down, RNA immunoprecipitation, qRT-PCR, and western blot analyses.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Genomic copy numbers of LINC01133 were increased in HCC, which were positively related with the elevated expression of LINC01133. Increased copy number of LINC01133 predicted the poor prognosis in HCC patients. LINC01133 overexpression in HCC cells promoted proliferation and aggressive phenotypes in vitro, and facilitated tumor growth and lung metastasis in vivo, whereas LINC01133 knockdown had the opposite effects. LINC01133 sponged miR-199a-5p, resulting in enhanced expression of SNAI1, which induced epithelial-to-mesenchymal transition (EMT) in HCC cells. In addition, LINC01133 interacted with Annexin A2 (ANXA2) to activate the ANXA2/STAT3 signaling pathway.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>LINC01133 promotes HCC progression by sponging miR-199a-5p and interacting with ANXA2. LINC01133 CNV gain is predictive of poor prognosis in patients with HCC.</p></section>

LncRNA PCNAP1 modulates hepatitis B virus replication and enhances tumor growth of liver cancer.

LncRNA PCNAP1 Promotes Hepatoma Cell Proliferation through Targeting miR-340-5p and is Associated with Patient Survival

Lncrna PCBP1-AS1 Aggravates the Progression of Hepatocellular Carcinoma Via Regulating PCBP1/PRL-3/AKT Pathway

Hepatitis B Virus P Protein Initiates Glycolytic Bypass in HBV-related Hepatocellular Carcinoma Via a FOXO3/miRNA-30b-5p/MINPP1 Axis

A Double-Edged Sword: the HBV-induced Non-Coding RNAs Alterations in Hepatocellular Carcinoma

Hepatitis B Virus X Protein-Mediated Non-Coding RNA Aberrations in the Development of Human Hepatocellular Carcinoma

Upregulation of a Novel LncRNA AC104958.2 Stabilized by PCBP2 Promotes Proliferation and Microvascular Invasion in Hepatocellular Carcinoma.

Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans.

HBx-upregulated lncRNA UCA1 promotes cell growth and tumorigenesis by recruiting EZH2 and repressing p27Kip1/CDK2 signaling

Antisense long non-coding RNA PCNA-AS1 promotes tumor growth by regulating proliferating cell nuclear antigen in hepatocellular carcinoma.

Retraction Note: HBx/ERα Complex-Mediated LINC01352 Downregulation Promotes HBV-related Hepatocellular Carcinoma Via the Mir-135B-apc Axis.

PCNA Confers the Conversion of Hepatitis B Virus Relaxed Circular DNA to Covalently Closed Circular DNA by Its DNA Binding Domain

Hepatitis B Virus-Upregulated LNC-HUR1 Promotes Cell Proliferation and Tumorigenesis by Blocking p53 Activity.

Pseudogene SNRPFP1 derived long non-coding RNA facilitates hepatocellular carcinoma progress in vitro by sponging tumor-suppressive miR-126-5p

LncRNA HANR Promotes Tumorigenesis and Increase of Chemoresistance in Hepatocellular Carcinoma.

The long noncoding RNA PCAT-1 links the microRNA miR-215 to oncogene CRKL-mediated signaling in hepatocellular carcinoma

Suppression of Hepatocellular Carcinoma Progression by Long Noncoding RNA Apolipoprotein C1 Pseudogene Via the Regulation of the Microrna-106B-pten Axis

Hepatitis B Virus Infection Promotes Hepatocellular Carcinoma Progression Through LPC/ENPP2/LPA Axis

The Long Noncoding RNA Lncparp1 Contributes to Progression of Hepatocellular Carcinoma Through Up-Regulation of PARP1

LINC01133 promotes hepatocellular carcinoma progression by sponging miR‐199a‐5p and activating annexin A2

The Association Of Lncrna Snps And Snps-Environment Interactions Based On Gwas With Hbv-Related Hcc Risk And Progression